Craig Philips

Companies

• Proteostasis Therapeutics (United States)President Dec 20, 2022 to now¹
• CTI BioPharmaPresident Aug 8, 2008 to Jul 3, 2012²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• PTProteostasis Therapeutics (United States)0 shares³Jun 30, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 30, 2025Returned to company 34,654 shares of Proteostasis Therapeutics (United States)³
• Jun 30, 2025Returned to company 298,464 shares of Proteostasis Therapeutics (United States)³
• Jun 25, 2025Granted 60,300 shares of Proteostasis Therapeutics (United States)⁴
• Jun 23, 2025Shares withheld for tax 47,647 shares at $0.26 of Proteostasis Therapeutics (United States)⁴
• Jun 23, 2025Exercised options 225,000 shares at $0.36 of Proteostasis Therapeutics (United States)⁴
• Nov 28, 2023Bought 3,000 shares at $3.27 of Proteostasis Therapeutics (United States)⁵
• Sep 21, 2023Bought 2,900 shares at $2.40 of Proteostasis Therapeutics (United States)⁶
• Sep 20, 2023Bought 600 shares at $2.54 of Proteostasis Therapeutics (United States)⁶
• Jun 14, 2023Shares withheld for tax 12,666 shares at $2.82 of Proteostasis Therapeutics (United States)⁷
• Jun 14, 2023Exercised options 1,382 shares at $0.14 of Proteostasis Therapeutics (United States)⁷
• Mar 20, 2023Sold 872 shares at $3.29 of Proteostasis Therapeutics (United States)⁸
• Mar 17, 2023Sold 1 shares at $5.25 of Proteostasis Therapeutics (United States)⁸
• Mar 17, 2023Sold 34 shares at $5.23 of Proteostasis Therapeutics (United States)⁸
• Mar 17, 2023Sold 1,196 shares at $4.94 of Proteostasis Therapeutics (United States)⁸
• Dec 16, 2022Granted 8,658 shares at $11.55 of Proteostasis Therapeutics (United States)⁹
• Dec 16, 2022Granted 24,614 shares of Proteostasis Therapeutics (United States)⁹
• Dec 16, 2022Granted 6,880 shares of Proteostasis Therapeutics (United States)⁹
• Dec 16, 2022Granted 55,223 shares of Proteostasis Therapeutics (United States)⁹
• Dec 16, 2022Granted 6,977 shares of Proteostasis Therapeutics (United States)⁹